Public Charity

The Salk Institute for Biological Studies

The Salk Institute for Biological Studies is a Public Charity headquartered in LA JOLLA, CA. Financial data from the 2025 filing: $181.4M revenue, $176.9M expenses, $836.1M total assets. 370 publicly reported grants to this organization, totaling roughly $170.2M, appear in IRS filings.

EIN: 952160097 LA JOLLA, CA Biological & Life Sciences NTEE: U50 Latest filing: 2025
Total Revenue$181.4M
Total Expenses$176.9M
Total Assets$836.1M
Grant Records370
Funding Total$170.2M
Filing Years2021–2025

Mission

UNLOCKING THE SECRETS OF LIFE ITSELF IS THE DRIVING FORCE BEHIND THE SALK INSTITUTE. OUR TEAM OF WORLD-CLASS, AWARD-WINNING SCIENTISTS PUSHES BOUNDARIES OF KNOWLEDGE IN AREAS SUCH AS NEUROSCIENCE, CANCER RESEARCH, AGING, IMMUNOBIOLOGY, PLANT BIOLOGY, COMPUTATIONAL BIOLOGY, AND MORE. FOUNDED BY JONAS SALK, DEVELOPER OF THE FIRST SAFE AND EFFECTIVE POLIO VACCINE, THE INSTITUTE IS AN INDEPENDENT, NONPROFIT RESEARCH ORGANIZATION AND ARCHITECTURAL LANDMARK: SMALL BY CHOICE, INTIMATE BY NATURE, AND FEARLESS IN THE FACE OF ANY CHALLENGE.

Where $100 goes at The Salk Institute for Biological Studies

How The Salk Institute for Biological Studies divides every $100 it spends, from its own Form 990 filings, averaged across 10 years.

$84 Programs the work itself
$13 Management running the organization
$3 Fundraising raising the next dollar

Inside the $84 for programs

$84
The Salk Institute for Biological Studies is a world-renowed, independent research institute dedicated to advancing our understanding of life sciences and improving human health
All program spending
Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Sample Grants Received

2025
SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.
$849,414
2025
THE ROLE OF ASTROCYTE-SECRETED IGFBP2 IN THE PROGRESSION OF ALZHEIMER'S DISEASE
$201,250
$1,686,000
2024
GRANTS FOR SCIENTIFIC RESEARCH
$1,157,441
2024
Program Support
$1,025,000

Showing up to 5 of 370 total records — full history available with membership.

Officers & Directors

TRUSTEE Amy Jacobs
TRUSTEE Benjamin H Lewis
TRUSTEE Carol Gallagher Pharmd
TRUSTEE/PROFESSOR (INCOMING APR 2025) Christian Metallo Phd
TRUSTEE Corinne Mentzelopoulos
TRUSTEE (OUTGOING NOV 2024) Daniel C Lewis

Officer compensation and complete director data available with membership.

Top Grant Purposes

General Support
$61,564,787 108 grants
Research & Policy
$45,537,594 119 grants
Health & Medicine
$44,332,429 71 grants
Civil Rights & Social Justice
$8,359,623 1 grant
Fundraising & Sponsorship
$4,298,651 10 grants

Financial Trends

Year Revenue Expenses Assets
2025 $181.4M $176.9M $836.1M
2024 $161.2M $177.2M $822.8M
2023 $173.7M $167.4M $805.3M
2022 $162.3M $161.4M $759.8M
2021 $211.2M $148.4M $802.9M

Between 2021 and 2025, reported annual revenue declined from $211.2M to $181.4M (-14%), with total assets most recently reported at $836.1M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for The Salk Institute for Biological Studies

Complete financials, all 370 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time